Cencora COR 深 滬
等待開盤 10-08 09:30:00 美东时间
317.25
+0.880
+0.28%
華盛通- 最 高322.41
- 今 開317.30
- 成交量 106.08万股
- 最 低 315.15
- 昨 收 316.37
- 總市值 605.40亿
- 52周最高 375.74
- 市盈率 靜 39.85
- 換手率 0.56%
- 52周最低 243.62
- 委 比 90.48%
- 總股本 1.91亿
- 歷史最高 375.74
- 量 比 0.78
- 振 幅 2.29%
- 歷史最低 -9.225
- 每 手 1
- 風險率 29.11%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Leerink Partners Maintains Outperform on Cencora, Raises Price Target to $388
Leerink Partners analyst Michael Cherny maintains Cencora (NYSE:COR) with a Outperform and raises the price target from $380 to $388.
今天 00:56
Stock index futures mixed ahead of FOMC minutes
Stock index futures were mixed on Wednesday as traders looked forward to the release of the Federal Reserve's latest meeting minutes later in the day. Dow futures (INDU) -0.06%, S&P 500 futures (SPX) ...
10-07 16:39
Harrow Closes Acquisition of TYRVAYA®
Harrow acquired TYRVAYA, the first FDA-approved nasal spray for dry eye disease (DED), expanding its ocular surface franchise. TYRVAYA, a cholinergic agonist, stimulates basal tear production via the trigeminal parasympathetic pathway and is approved in the U.S., China, and Taiwan. The acquisition includes worldwide rights except Japan, with Viatris retaining commercialization rights there. Harrow paid $30 million upfront, with up to $70 million ...
10-05 11:00
$100 Invested In Cencora 5 Years Ago Would Be Worth This Much Today
Cencora (NYSE:COR) has outperformed the market over the past 5 years by 8.44% on an annualized basis producing an average annual return of 20.45%. Currently, Cencora has a market capitalization of $57.98 billion. Buying $100 In COR: If an investor had bought $100 of COR stock 5 years ago, it would b...
09-29 04:30
Cencora Adds Independent Director to Support Growth Strategy
An update from Cencora ( ($COR) ) is now available. On September 24, 2026, Cenc...
09-25 20:27
$1000 Invested In Cencora 10 Years Ago Would Be Worth This Much Today
Cencora (NYSE:COR) has outperformed the market over the past 10 years by 6.79% on an annualized basis producing an average annual return of 20.35%. Currently, Cencora has a market capitalization of $61.36 billion. Buying $1000 In COR: If an investor had bought $1000 of COR stock 10 years ago, it wou...
09-12 06:00
美股大行评级 | 多家大行齐上调Robinhood目标价！最高看至150美元；安进股价大跌后评级遭下调
今日重点评级关注：Chardan Capital：维持Hyperion DeFi"买入"评级，目标价从7.3美元升至8.45美元；摩根大通：维持Vera Therapeutics"超配"评级，目标价从76美元升至83美元
09-09 15:36
RBC Capital Reiterates Sector Perform on Cencora, Maintains $330 Price Target
RBC Capital analyst Ryan Halsted reiterates Cencora (NYSE:COR) with a Sector Perform and maintains $330 price target.
09-08 22:37
美股大行评级 | 潜在涨幅1610.53%！Ascendiant Capital上调Alzamend Neuro目标价至26美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持Alzamend Neuro"买入"评级，目标价从25美元升至26美元；Tigress Financial：维持Legence"买入"评级，目标价从125美元升至130美元
08-20 08:39
If You Invested $1000 In Cencora Stock 10 Years Ago, You Would Have This Much Today
Cencora (NYSE:COR) has outperformed the market over the past 10 years by 6.29% on an annualized basis producing an average annual return of 19.83%. Currently, Cencora has a market capitalization of $59.16 billion. Buying $1000 In COR: If an investor had bought $1000 of COR stock 10 years ago, it wou...
08-14 04:45
